Inventor
SAHOO SOUMYA P
US33 patents
⚠️ This page may combine multiple inventors who share the name “SAHOO SOUMYA P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
28 patentsUS6200998B1Mar 13, 2001
Arylthiazolidinedione derivitives
MERCK & CO INC84 citations96
US6645974B2Nov 11, 2003
Androgen receptor modulators and methods for use thereof
MERCK & CO INC63 citations95
US5859051AJan 12, 1999
Antidiabetic agents
MERCK & CO INC150 citations95
US6008237ADec 28, 1999
Arylthiazolidinedione derivatives
MERCK & CO INC57 citations94
US6713508B2Mar 30, 2004
Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
MERCK & CO INC27 citations92
US5910497AJun 8, 1999
16-pyrazinyl-substituted-4-aza-androstane 5-α-reductase isozyme 1 inhibitors
MERCK & CO INC18 citations92
US5719158AFeb 17, 1998
16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors
MERCK & CO INC22 citations92
US5693809ADec 2, 1997
Substituted 4-aza-5α-androstan-ones as 5α-reductase inhibitors
MERCK & CO INC37 citations92
US6090836AJul 18, 2000
Benzisoxazole-derived antidiabetic compounds
MERCK & CO INC24 citations91
US5591737AJan 7, 1997
Substituted azetidinones as anti-inflammatory and antidegenerative agents
MERCK & CO INC18 citations84
US5739137AApr 14, 1998
16-substituted-4-aza-3-oxo-androstane as 5-alpha-reductase isozyme 1 inhibitors
MERCK & CO INC14 citations82
US5001123AMar 19, 1991
2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
MERCK & CO INC20 citations81
US4996203AFeb 26, 1991
2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
MERCK & CO INC20 citations81
US6001844ADec 14, 1999
4-Azasteroids for treatment of hyperandrogenic conditions
MERCK & CO INC12 citations74
US5010100AApr 23, 1991
Certain 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
MERCK & CO INC9 citations74
US6645997B2Nov 11, 2003
Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
MERCK & CO INC8 citations73
US5763361AJun 9, 1998
17-alkyl-7-substituted-4-aza steroid derivatives as 5-α-reductase inhibitors
MERCK & CO INC13 citations73
US6399640B1Jun 4, 2002
Arylthiazolidinedione and aryloxazolidinedione derivatives
MERCK & CO INC9 citations72
US7319170B2Jan 15, 2008
N-cyclohexylaminocarbonyl benzensulfonmide derivatives
MERCK & CO INC6 citations63
US5658922AAug 19, 1997
4-aza-pregnane 5α-reductase isozyme 1 inhibitors
MERCK & CO INC3 citations63
US5679700AOct 21, 1997
Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
MERCK & CO INC5 citations62
US5114961AMay 19, 1992
2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
MERCK & CO INC3 citations61
US6380191B1Apr 30, 2002
Arylthiazolidinedione and aryloxazolidinedione derivatives
MERCK & CO INC3 citations60
US5932551AAug 3, 1999
Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative active agents
MERCK & CO INC6 citations60
USRE39056EApr 4, 2006
4-Azasteroids for treatment of hyperandrogenic conditions
MERCK & CO INC0 citations52
US6204273B1Mar 20, 2001
16-substituted-4-aza-androstane 5-α-reductase isozyme 1 inhibitors
MERCK & CO INC0 citations52
US6143887ANov 7, 2000
Process for the stereoselective synthesis of 16-substituted-4-aza-androstanones
MERCK & CO INC0 citations50
US6465497B2Oct 15, 2002
Arylthiazolidinedione derivatives
MERCK & CO INC1 citations49